Skip to main content
FERMENTA BIOTECH LIMITED logo

FERMENTA BIOTECH LIMITED — Investor Relations & Filings

Ticker · FERMENTA ISIN · INE225B01021 LEI · 335800VNTNWW8G1U9314 BSE.NS Manufacturing
Open in API
Filings indexed 671 across all filing types
Latest filing 2024-08-23 Investor Presentation
Country IN India
Listing BSE.NS FERMENTA

About FERMENTA BIOTECH LIMITED

https://fermentabiotech.com

Fermenta Biotech Limited is a specialized biotechnology company primarily focused on the development and manufacture of Vitamin D3 (Cholecalciferol). As one of the few vertically integrated manufacturers globally, the company produces Vitamin D3 for diverse applications, including pharmaceuticals, dietary supplements, human nutrition, and animal feed. Beyond its core Vitamin D3 portfolio, the company offers a range of specialty enzymes, particularly for the synthesis of beta-lactam antibiotics, and provides environmental solutions through its biotechnology expertise. Fermenta Biotech emphasizes high-quality standards, maintaining various international certifications for its manufacturing facilities. Its product offerings extend to premixes and value-added formats designed to meet specific formulation requirements. The company serves a global clientele, leveraging its research and development capabilities to innovate in the fields of nutrition and biotechnology.

Recent filings

Filing Released Lang Actions
Earnings Presentation Q1-FY25
Investor Presentation Classification · 95% confidence The document is titled 'Earnings Presentation for Quarter 1 of Financial Year 2024-25 (Q1-FY25)' and contains detailed financial data including standalone and consolidated revenue, EBITDA margins, income statements, balance sheets, and operational highlights for Q1-FY25. It includes quarterly and historical financial performance data, operational metrics, and business overview. The document is approximately 15,000 characters long, indicating it is a full presentation rather than a brief announcement. The content is consistent with a detailed investor presentation focusing on quarterly financial results and company strategy. Therefore, the document fits the category of an Investor Presentation (IP) rather than a simple Earnings Release (ER) or Interim Report (IR), as it provides comprehensive financial and operational details in a presentation format.
2024-08-23 English
Loss of share certificates
Regulatory Filings Classification · 100% confidence The document is a formal letter addressed to the stock exchange (BSE Limited) regarding the loss of share certificates, citing Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It provides details of the lost share certificates and is an intimation for regulatory compliance purposes. The document is short (1346 characters) and serves as a notification rather than a financial report or detailed filing. It does not contain financial data, management discussion, voting results, or any other report content. This type of document fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2024-08-21 English
Details of Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the stock exchange (BSE Limited) regarding the loss of share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to the intimation of loss of share certificates. The content is an official notification for regulatory compliance and record-keeping, not a financial report, earnings release, or any other detailed corporate filing. The document length is short (1411 characters) and it serves as an announcement of a specific event (loss of share certificates) rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-08-20 English
Issue of Duplicate Share certificate
Regulatory Filings Classification · 100% confidence The document is an intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the issue of duplicate share certificates to shareholders. It is addressed to the stock exchange and provides details of the duplicate share certificates issued. The document is a regulatory announcement related to share certificate issuance and does not contain financial statements, management discussion, or other report content. It is a compliance notification under SEBI regulations, fitting the category of Regulatory Filings (RNS). The document length is short and it is not a report or announcement of a report publication, so it is not RPA. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-08-19 English
Newspaper publication of unaudited financial results for the quarter ended June 30, 2024
Regulatory Filings
2024-08-13 English
Outcome and proceedings of 72nd Annual General Meeting
AGM Information Classification · 95% confidence The document is a detailed communication addressed to the stock exchange (BSE Limited) regarding the outcome and proceedings of the 72nd Annual General Meeting (AGM) of Fermenta Biotech Limited. It includes information about the appointment and continuation of directors, dividend declaration, summary of the AGM proceedings, voting details, and resolutions passed. The document references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events including AGM outcomes. The content is focused on the AGM event itself, including the summary of proceedings and resolutions passed, rather than the full annual report or financial statements. The document length is 8308 characters, which is consistent with a detailed AGM outcome announcement rather than a full Annual Report or other financial report. Therefore, the document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or the official outcome and proceedings of the AGM.
2024-08-12 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.